Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2013 3
2015 1
2019 1
2020 1
2021 3
2022 8
2023 2
2024 8
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study.
Zirwas M, Fowler JF Jr, Tsianakas A, Devani AR, Halden P, Lai Z, Kuo Y, Nawaz H, Stein Gold LF. Zirwas M, et al. Among authors: devani ar. J Am Acad Dermatol. 2026 Jan;94(1):32-40. doi: 10.1016/j.jaad.2025.08.081. Epub 2025 Aug 30. J Am Acad Dermatol. 2026. PMID: 40889714 Free article. Clinical Trial.
Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study.
Eichenfield LF, Stein Gold LF, Simpson EL, Zaenglein AL, Armstrong AW, Tollefson MM, Soong W, Wine Lee L, Devani AR, Forman SB, Siri DD, Kallender H, Angel B, Li Q, Chen X, Paller AS. Eichenfield LF, et al. Among authors: devani ar. J Am Acad Dermatol. 2025 Sep;93(3):689-698. doi: 10.1016/j.jaad.2025.05.1385. Epub 2025 May 14. J Am Acad Dermatol. 2025. PMID: 40378883 Free article. Clinical Trial.
Response to Potestio et al., "Comment on Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review".
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: devani ar. J Am Acad Dermatol. 2025 Jun;92(6):e191-e193. doi: 10.1016/j.jaad.2024.11.083. Epub 2025 Feb 14. J Am Acad Dermatol. 2025. PMID: 39955006 No abstract available.
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: devani ar. Am J Clin Dermatol. 2025 Mar;26(2):301-304. doi: 10.1007/s40257-025-00922-2. Epub 2025 Feb 3. Am J Clin Dermatol. 2025. PMID: 39900871 No abstract available.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: devani ar. J Am Acad Dermatol. 2025 May;92(5):1093-1095. doi: 10.1016/j.jaad.2024.12.034. Epub 2025 Jan 20. J Am Acad Dermatol. 2025. PMID: 39831882 Free article. No abstract available.
CPAP Therapy for OSA and Its Impact on Various Cardiovascular Disorders.
Kumari K, Khalaf J, Sawan LJ, Ho WL, Murugan CK, Gupta A, Devani A, Rizwan M, Kaku R, Muzammil MA, Nageeta F. Kumari K, et al. Among authors: devani a. Cardiol Rev. 2025 Jan 14. doi: 10.1097/CRD.0000000000000843. Online ahead of print. Cardiol Rev. 2025. PMID: 39807867
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review.
Rankin BD, Sood S, Park YJ, Rimke A, Abduelmula A, Georgakopoulos JR, Maliyar K, Leung F, Stark LA, Devani AR, Yeung J, Prajapati VH. Rankin BD, et al. Among authors: devani ar. Dermatitis. 2025 Jul-Aug;36(4):e407-e409. doi: 10.1089/derm.2024.0208. Epub 2024 Oct 24. Dermatitis. 2025. PMID: 39446652 No abstract available.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: devani ar. J Am Acad Dermatol. 2024 Dec;91(6):1265-1267. doi: 10.1016/j.jaad.2024.07.1515. Epub 2024 Aug 23. J Am Acad Dermatol. 2024. PMID: 39182686 Free article. No abstract available.
35 results